Emerging Graphene Technology Company

Hydrothermal Graphite Deposit Ammenable for Commercial Graphene Applications

Free
AGORACOM NEWS FLASH

BREAKING: Else Nutrition Announces North American Launch of World's Only Real Alternative to Dairy-Based Baby Nutrition

  • Baby Nutrition Paradigm shift: After 120 years, Else introduces a completely novel protein source for baby nutrition (over one year old) with a breakthrough, clean and sustainable production process
  • Globally patented, and founded by infant nutrition industry veterans, Else Nutrition is the first dairy and soy- free, clean label, plant-based complete nutrition for babies (1 year and over)
  • Else Plant-Based Complete Nutrition is now available for purchase at elsenutrition.com, U.S. shipping nationwide and to Canada

Else large

Hub On AGORACOM / Read Release

Message: STOCKWATCH article on Zen Graphene Solutions

Undernoted is an excerpt from STOCKWATCH about Zen. They have done this before, where they end the article demeaning Zen and its' accomplishments. Does anyone know why this happens ? Do they have some kind of grudge against Zen ?

 


" Dr. Francis Dube's Zen Graphene Solutions Ltd. (ZEN), up three cents to 62 cents on 144,000 shares, is ramping up its promotion of a "antiviral, graphene-based ink formulation," a product for which it has "commenced collaborations with research teams at a number of personal protective equipment manufacturers." Essentially, Zen, a busy promoter of things graphene and a laggard developer of a graphite mine, wants to make masks to combat the spread of COVID-19. Dr. Dube, president and CEO, says that based on results so far and continuing discussions, Zen is "quickly moving" to integrate its material into commercial products.

Meanwhile, there has been little progress at the "unique Albany graphite project" in Northern Ontario since the company produced a dream sheet in 2016. Albany hosts 25.1 million tonnes indicated at 3.89 per cent graphite and 20.1 million tonnes inferred at just 2.2 per cent. Zen's stock had been as high as $5 in 2013, but the 2015 resource estimate halved its share price and a preliminary economic assessment in 2016 halved it again, once it became apparent that Albany was deemed capable of generating millions, not billions, of value for shareholders. "

Share
New Message
Please login to post a reply